Homepage > Company > Media > Pharma News > 2017 > Teva releases Minastrin generic

Teva releases Minastrin generic

JERUSALEM — Teva Pharmaceutical Industries on Monday launched an authorized Generic of Minastrin 24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) 1 mg/20 mcg in the United States.

The authorized generic is an estrogen/progestin combined oral contraceptive indicated for use by women to prevent pregnancy.

Картинки по запросу norethindrone acetate

Minastrin 24 Fe, manufactured by Allergan had annual sales of approximately $361 million in the U.S. according to IMS data as of December 2016.

March 20, 2017

http://www.drugstorenews.com/

Read also

FDA warns vs fake versions of popular medicines

MANILA, Philippines - counterfeit versions of some popular over-the-counter pain relievers and flu medicines are circulating in the market, the Food and Drug Administration (FDA) reported. ...

Japan's Eisai inks $2 B oncology deal with China-based startup Bliss Biopharma

Cognixion, a developer of non-invasive Brain-Computer Interface (BCI) and Augmented Reality (AR) technology, has announced that the US Food and Drug Administration (FDA) has granted its device Brea...

Cognixion receives FDA Breakthrough Device Designation for assisted communication device

EMA to review CTIS transparency rules

Public consultation seeks the best methods for balancing transparency with confidentiality in the EU Clinical Trials Information System, says the European Medicines Agency. ...